CVS Pharmacy reported on Friday the launch of the Hepatitis A vaccine programme in Kentucky following a rise in confirmed cases of the virus across the state.
According to the Kentucky Department for Public Health, more than 300 Hepatitis A cases have reportedly been confirmed across the state since 2017. Most recently, cases have been confirmed in Ashland, Berea and Louisville.
All 79 CVS Pharmacy locations in Kentucky, including the nine CVS Pharmacy in Target locations, have the Hepatitis A vaccine available for people who have not yet been vaccinated. The stores located in Ironton, OH and Kenova, WV as well as the three MinuteClinic locations in Kentucky have the vaccine in stock.
Consumers can visit CVS.com or use the CVS Pharmacy app to locate a nearby CVS Pharmacy and to schedule a Hepatitis A vaccination appointment. CVS pharmacists can provide the Hepatitis A vaccine to people ages 18 and up. It is administered in one primary dose and a second booster dose. Vaccine supplies will be replenished at the locations as needed. Patients should check with their insurance plans for coverage details prior to their CVS Pharmacy visit.
CVS Pharmacy is America's leading retail pharmacy with over 9,800 locations and the retail division of CVS Health (NYSE:CVS).
Anixa Biosciences transfers breast cancer vaccine IND from Cleveland Clinic
Sanofi completes acquisition of Vicebio to expand respiratory vaccines portfolio
Valneva reports positive final Phase 2 results for Lyme disease vaccine VLA15
Lunai Bioworks receives first LOI to license next-generation immune cell therapy
BioNet receives positive opinion from EMA for VacPertagen marketing authorisation in EU
Anixa Biosciences secures U.S. Patent strengthening breast cancer vaccine IP into mid 2040s
PharmaJet® and EVA Pharma Partner to Scale Needle-free Polio Immunisation Across Egypt
Frontier IP portfolio company achieves breakthrough in livestock vaccine trials
GC Biopharma's Phase 2 clinical trial results for BARYTHRAX published in Vaccine
Bavarian Nordic secures new EU contract for up to 8 million smallpox and mpox vaccine doses